Both China and the EU face heavy trade pressure from the White House. Trump’s tariffs on China remain at 30% even after the ...

Before filing for an IPO in the US, Ximalaya raised close to RMB 10 billion (USD 1.4 billion) over 12 funding rounds. Its cap ...

Laifen is sinking serious money into shavers, wagering that innovation will help it trump incumbents like Philips and Braun.

In China, Manus has made waves by claiming it has the world’s “first general AI agent” that can do everything from screening ...

As a wave of cost-consciousness sweeps across China, businesses offering quality at a discount have seen earnings surge while ...

Digit aims to commercialize humanoid robotics that reflect the potential of artificial general intelligence (AGI). Its core ...

Nooka turns books into conversational podcasts, creating a new form of content where storytelling starts with dialogue.

The EV maker projects a recovery, but with a steep deficit and mounting competition, hitting its 50,000-unit monthly target ...

Atome, a buy now, pay later (BNPL) platform under Advance Intelligence Group, has secured a USD 75 million asset-backed ...

Once awash in hype and capital, players like Barley are returning to medical fundamentals to rebuild trust and value.

AstraZeneca and CSPC Pharmaceutical have signed a research deal worth up to USD 5.3 billion to co-develop oral therapies for chronic and immunological diseases. CSPC will lead discovery in China using ...

For AI-driven fortune-telling to improve, models require training on high-quality, structured, real-world cases, and such ...